Surgical Innovations Group plc
SUN.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.78 | -0.00 | -0.01 | 0.14 |
| FCF Yield | -4.04% | 8.24% | -14.23% | 2.30% |
| EV / EBITDA | 21.26 | -5.40 | -40.38 | 62.99 |
| Quality | ||||
| ROIC | 0.63% | -4.78% | -1.11% | -0.90% |
| Gross Margin | 31.26% | 24.30% | 32.94% | 22.71% |
| Cash Conversion Ratio | -11.38 | -0.31 | 1.08 | -3.79 |
| Growth | ||||
| Revenue 3-Year CAGR | 14.77% | 11.98% | 14.63% | 7.31% |
| Free Cash Flow Growth | -162.41% | 175.00% | -537.21% | 130.94% |
| Safety | ||||
| Net Debt / EBITDA | 3.75 | -0.91 | -5.90 | 4.69 |
| Interest Coverage | 1.53 | -11.59 | -2.33 | -4.53 |
| Efficiency | ||||
| Inventory Turnover | 1.62 | 1.47 | 1.25 | 1.72 |
| Cash Conversion Cycle | 68.98 | 66.92 | 75.64 | 30.83 |